Cargando…
Asprosin: A Novel Player in Metabolic Diseases
Asprosin, a novel glucogenic adipokine, is encoded by two exons (exon 65 and exon 66) of the gene Fibrillin 1 (FBN1) and mainly synthesized and released by white adipose tissue during fasting. Asprosin plays a complex role in the central nervous system (CNS), peripheral tissues, and organs. It is in...
Autores principales: | Yuan, Mingyang, Li, Weidong, Zhu, Yan, Yu, Boyao, Wu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045041/ https://www.ncbi.nlm.nih.gov/pubmed/32153505 http://dx.doi.org/10.3389/fendo.2020.00064 |
Ejemplares similares
-
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects
por: Farrag, Mariam, et al.
Publicado: (2023) -
The Effects of Asprosin on Exercise-Intervention in Metabolic Diseases
por: Liu, Lifei, et al.
Publicado: (2022) -
ODP428 The Effects of Asprosin Pubertal Maturation in Female Rats
por: OZ, Zeynep Dila, et al.
Publicado: (2022) -
FRI390 The Effects Of Chronic Asprosin Administration On Ovarian Tissue
por: Kelestimur, Haluk, et al.
Publicado: (2023) -
Meal-Related Asprosin Serum Levels Are Affected by Insulin Resistance and Impaired Fasting Glucose in Children With Obesity
por: Corica, Domenico, et al.
Publicado: (2022)